Advertisement
Largest study of epilepsy genetics identifies polygenic risk score
Retrospective clinic-based study provides intriguing initial comparisons
Findings hint at potentially easier treatment initiation vs. other S1P receptor modulators
Benefits of novel PET radiotracer expected to go beyond multiple sclerosis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
DoD grant supports creation, validation of multidimensional field assessments
Newly discovered signaling loop is shown to be druggable
New clinical trials size up an immunomodulator’s pleiotropic effects
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging
Advertisement
Advertisement